Nanobodies, single-domain antigen-binding fragments of camelid-specific heavy-chain only
antibodies offer special advantages in therapy over classic antibody fragments because of …

Nanobodies are a novel type of immunoglobulinlike, antigen-binding protein with beneficial
pharmacologic and pharmacokinetic properties that are ideally suited to targeting cellular …

Nanobodies are recombinant, antigen-specific, single-domain, variable fragments of camelid
heavy chain-only antibodies. The innate supremacy of nanobodies as a renewable source …

Envenoming following scorpion sting is a common emergency in many parts of the world.
Our aim was to ameliorate the current 100‐kDa horse plasma antivenom serum (PAS)‐derived …

Accurate determination of tumor human epidermal growth factor receptor 2 (HER2)‐status in
breast cancer patients is possible via noninvasive imaging, provided adequate tracers are …

Nanobodies are the smallest fully functional antigen-binding antibody fragments possessing
ideal properties as probes for molecular imaging. In this study we labeled the anti–human …

RIT has become an attractive strategy in cancer treatment, but still faces important drawbacks
due to poor tumor penetration and undesirable pharmacokinetics of the targeting vehicles. …

The antigen-binding fragment of functional heavy chain antibodies (HCAbs) in camelids
comprises a single domain, named the variable domain of heavy chain of HCAbs (VHH). The …

Immunizing a camelid (camels and llamas) with soluble, properly folded proteins raises an
affinity-matured immune response in the unique camelid heavy-chain only antibodies (HCAbs…

To quantify and characterize the potentially toxic protein aggregates associated with
neurodegenerative diseases, a high‐throughput assay based on measuring the extent of aggregate…